Chemotherapy At Home Services Market Report 2026

Chemotherapy At Home Services Market Overview

• Chemotherapy At Home Services market size has reached to $1.94 billion in 2025 • Expected to grow to $3.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Growing Cancer Rates Propel Demand For Home-Based Chemotherapy Services • Market Trend: Innovative At-Home Cancer Care Programs Driving The Shift Toward Patient-Centric Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chemotherapy At Home Services Market?

Chemotherapy at home services is an outpatient care option provided by a team of doctors and nurses, allowing cancer patients to receive their treatments at home. Chemotherapy at-home services provide cancer patients with the option to receive chemotherapy treatments in the comfort of their own homes rather than in traditional clinical settings such as hospitals or specialized treatment centers. The products of chemotherapy at-home services included are chemotherapy drugs and chemotherapy infusion pumps. Chemotherapy drugs are medications used to treat cancer by targeting and destroying cancer cells. It includes administration such as oral, and intravenous. It is provided for applications such as breast cancer, blood cancer, ovarian cancer, and colorectal cancer.

What Is The Chemotherapy At Home Services Market Growth Forecast?

The chemotherapy at home services market size is expected to see strong growth in the next few years. It will grow to $3.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing investments in home healthcare services, growing adoption of digital oncology monitoring tools, expansion of targeted cancer therapies, rising preference for decentralized care delivery, improved reimbursement support for home chemotherapy. Major trends in the forecast period include increasing adoption of home-based oncology care models, rising use of portable infusion technologies, growing integration of remote patient monitoring, expansion of personalized chemotherapy regimens, enhanced focus on patient comfort and safety.

Global Chemotherapy At Home Services Market Segmentation

1) By Product: Chemotherapy Drugs, Chemotherapy Infusion Pumps 2) By Administration: Oral, Intravenous 3) By Application: Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer Subsegments: 1) By Chemotherapy Drugs: Oral Chemotherapy Drugs, Injectable Chemotherapy Drugs, Targeted Therapy Drugs, Chemotherapy Regimen Combinations 2) By Chemotherapy Infusion Pumps: Portable Infusion Pumps, Home Infusion Therapy Pumps, Electronic Infusion Pumps, Ambulatory Infusion Pumps

What Are The Drivers Of The Chemotherapy At Home Services Market?

The increased prevalence of cancer is expected to propel the growth of the chemotherapy-at-home services market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. There is an increased prevalence of cancer due to several factors such as aging populations, lifestyle changes, environmental exposures, genetic predispositions, and increased detection through advanced diagnostic techniques. Chemotherapy at-home services allow cancer patients to receive treatment in the comfort of their own homes, improving convenience and quality of life. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, in the United States there were 1,958,310 new cancer cases, and 609,820 cancer deaths are projected to occur in 2023. Therefore, the increased prevalence of cancer is driving the growth of chemotherapy at-home services. The rising healthcare expenditure is expected to propel the growth of the chemotherapy at home services market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure supports the growth of chemotherapy-at-home services by enabling investment in cost-efficient, patient-centric cancer care models, expanding reimbursement, and improving the infrastructure needed to deliver safe oncology treatments at home. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the chemotherapy at home services industry.

Key Players In The Global Chemotherapy At Home Services Market

Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc, Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd, Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare

Global Chemotherapy At Home Services Market Trends and Insights

Major companies operating in the chemotherapy at home services market are increasingly focusing on expanding patient-centric care models through technology-enabled home-based oncology programs to improve treatment accessibility, enhance patient comfort, and reduce the burden on hospital systems. These programs integrate remote monitoring, virtual oncology support, and in-home nursing services to deliver safe, compliant chemotherapy outside traditional clinical settings. For instance, in April 2025, Reimagine Care, a US-based provider of technology-driven home-based oncology solutions, launched an at-home cancer care pilot in collaboration with MedStar Health. The initiative aims to extend oncology services, including symptom management, treatment support, and continuous virtual monitoring, into patients’ homes. By leveraging digital platforms, care navigation tools, and trained clinical teams, the pilot seeks to enhance patient experience, reduce hospital visits, and support more efficient delivery of oncology care across the MedStar Health network.

Regional Outlook

North America was the largest region in the chemotherapy at-home services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chemotherapy At Home Services Market?

The chemotherapy-at-home services market consists of revenues earned by entities by providing services such as telehealth support, and drug delivery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemotherapy-at-home services market also includes sales of portable infusion pumps, chemotherapy drug kits, and home care medical supplies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chemotherapy At Home Services Market Report 2026?

The chemotherapy at home services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy at home services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.